Literature DB >> 12499245

Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion.

Jesper Nylandsted1, Wolfgang Wick, Ulrich A Hirt, Karsten Brand, Mikkel Rohde, Marcel Leist, Michael Weller, Marja Jäättelä.   

Abstract

Heat shock protein 70 (Hsp70) is an antiapoptotic chaperone protein highly expressed in human tumors. Here we demonstrate that locoregional application of adenovirus expressing antisense Hsp70 cDNA (Ad.asHsp70) eradicates orthotopic xenografts of glioblastoma and breast carcinoma, as well as s.c. xenografts of colon carcinoma in immunodeficient mice. Ad.asHsp70-treated tumors showed massive apoptosis-like cell death and recruitment of macrophages. Human monocyte-derived macrophages effectively removed the corpses of Ad.asHsp70-treated tumor cells in vitro. Interestingly, both tumor cell death and phagocytosis were caspase-independent. Thus, Hsp70 appears as a promising target for the treatment of cancers resistant to classic caspase-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499245

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Heat shock protein 70 enhanced deoxyribonucleic acid base excision repair in human leukemic cells after ionizing radiation.

Authors:  Robert Bases
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

2.  Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.

Authors:  Tatjana Mijatovic; Véronique Mathieu; Jean-François Gaussin; Nancy De Nève; Fabrice Ribaucour; Eric Van Quaquebeke; Patrick Dumont; Francis Darro; Robert Kiss
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 3.  Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.

Authors:  David Lanneau; Aurelie de Thonel; Sebastien Maurel; Celine Didelot; Carmen Garrido
Journal:  Prion       Date:  2007-01-24       Impact factor: 3.931

Review 4.  Intake of ω-6 Polyunsaturated Fatty Acid-Rich Vegetable Oils and Risk of Lifestyle Diseases.

Authors:  Tetsumori Yamashima; Tsuguhito Ota; Eishiro Mizukoshi; Hiroyuki Nakamura; Yasuhiko Yamamoto; Mitsuru Kikuchi; Tatsuya Yamashita; Shuichi Kaneko
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.

Authors:  W-J Lu; N P Lee; S C Kaul; F Lan; R T P Poon; R Wadhwa; J M Luk
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

6.  Clonogenicity of human leukemic cells protected from cell-lethal agents by heat shock protein 70.

Authors:  Robert Bases
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

7.  Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms.

Authors:  Mikkel Rohde; Mads Daugaard; Mette Hartvig Jensen; Kristian Helin; Jesper Nylandsted; Marja Jäättelä
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

8.  Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.

Authors:  Karl F Schmidt; Mateo Ziu; Nils Ole Schmidt; Pramil Vaghasia; Theresa G Cargioli; Sameer Doshi; Mitchell S Albert; Peter McL Black; Rona S Carroll; Yanping Sun
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

9.  Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.

Authors:  Phan L C H B Tran; Soo-A Kim; Hong Seok Choi; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  BMC Cancer       Date:  2010-06-10       Impact factor: 4.430

Review 10.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.